Your browser doesn't support javascript.
loading
Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosis.
Berger, Daniela; Bauer, Karin; Kornauth, Christoph; Gamperl, Susanne; Stefanzl, Gabriele; Smiljkovic, Dubravka; Sillaber, Christian; Bettelheim, Peter; Knöbl, Paul; Schiefer, Ana-Iris; Greiner, Georg; Thalhammer, Renate; Hoermann, Gregor; Schwarzinger, Ilse; Staber, Philipp B; Sperr, Wolfgang R; Valent, Peter.
Affiliation
  • Berger D; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Bauer K; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria; Ludwig Boltzmann Institute for Hematology and Oncology (LBI HO), Medical University of Vienna, Vienna, Austria.
  • Kornauth C; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria; Ludwig Boltzmann Institute for Hematology and Oncology (LBI HO), Medical University of Vienna, Vienna, Austria; Department of Pathology, Medical University of Vienna, Vienna,
  • Gamperl S; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Stefanzl G; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Smiljkovic D; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Sillaber C; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Bettelheim P; Division of Hematology and Oncology, Elisabethinen Hospital Linz and Europa-Platz Labor Linz, Linz, Austria.
  • Knöbl P; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Schiefer AI; Department of Pathology, Medical University of Vienna, Vienna, Austria.
  • Greiner G; Ludwig Boltzmann Institute for Hematology and Oncology (LBI HO), Medical University of Vienna, Vienna, Austria; Ihr Labor, Medical Diagnostic Laboratories, Vienna, Austria; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Thalhammer R; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Hoermann G; Ludwig Boltzmann Institute for Hematology and Oncology (LBI HO), Medical University of Vienna, Vienna, Austria; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria; Munich Leukemia Laboratory (MLL), Munich, Germany.
  • Schwarzinger I; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Staber PB; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Sperr WR; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Valent P; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria. Electronic address: peter.valent@meduniwien.ac.at.
Neoplasia ; 23(12): 1183-1191, 2021 12.
Article in En | MEDLINE | ID: mdl-34731787
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Basophils / Myelodysplastic Syndromes / Leukemia / Neoplasms, Second Primary / Myeloproliferative Disorders Type of study: Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Neoplasia Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Austria Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Basophils / Myelodysplastic Syndromes / Leukemia / Neoplasms, Second Primary / Myeloproliferative Disorders Type of study: Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Neoplasia Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Austria Country of publication: Estados Unidos